Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo* (Q71809403)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586950%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586950%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo* (English)

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

26 May 2024

1 reference

A. K. Mitra

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586950

26 May 2024

K. E. Thummel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586950

26 May 2024

T. F. Kalhorn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586950

26 May 2024

E. D. Kharasch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586950

26 May 2024

J. D. Unadkat

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586950

26 May 2024

J. T. Slattery

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586950

26 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7586950

26 May 2024

publication date

1 November 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586950%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586950%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586950%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586950%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

556-566

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586950%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

2

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

New approaches to chemotherapy for leprosy

26 May 2024

3

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Pharmacokinetic observations on dapsone in dermatitis herpetiformis

26 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone

26 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions

26 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Microsomal N-Oxidation of Dapsone as a Cause of Methemoglobin Formation in Human Red Cells *

26 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Biochemical effects of aromatic amines. I. Methaemoglobinaemia, haemolysis and Heinz-body formation induced by 4,4'-diaminodiphenylsulphone.

26 May 2024

10

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients

26 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes

26 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Mechanism of methemoglobin formation by diphenylsulfones. Effect of 4-amino-4'-hydroxyaminodiphenylsulfone and other p-substituted derivatives

26 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

The in Vitro Action of Dapsone and its Derivatives on Normal and G6PD-deficient Red Cells

26 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Systemic glutathione deficiency in symptom-free HIV-seropositive individuals

26 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines

26 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

26 May 2024

17

41

975

Fleming C. M.

1992

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men

26 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Clinical pharmacokinetics of dapsone

26 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

4-Amino-4'-hydroxylaminodiphenyl sulfone, its acetyl and D-glucosyl derivatives

26 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Drug Metabolism and Disposition

26 May 2024

22

21

350

Thummel K. E.

1993

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4

26 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Protein measurement with the Folin phenol reagent

26 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?

26 May 2024

27

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

26 May 2024

29

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline

26 May 2024

30

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity

26 May 2024

31

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Identification of an inducible form of cytochrome P-450 in human liver

26 May 2024

32

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

26 May 2024

33

34

628

Namkung M. J.

1988

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes

26 May 2024

34

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9

26 May 2024

35

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

26 May 2024

36

30

287

Guengerich F. P.

1986

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects

26 May 2024

37

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes

26 May 2024

38

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

26 May 2024

39

36

89

Kronbach T.

1989

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1

26 May 2024

40

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.

26 May 2024

41

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro

26 May 2024

42

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

The pharmacology and toxicology of disulfiram and its metabolites

26 May 2024

43

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites

26 May 2024

44

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90176-0

26 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586950%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference